Read + Share
Hummelink K, van der Noort V, Muller M, Schouten RD, et al. PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in
Patients with Advanced NSCLC. Clin Cancer Res 2022;28:4893-4906.
PMID: 35852792
|
 |
|
Hummelink K, van der Noort V, Muller M, Schouten RD, et al. PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in
Patients with Advanced NSCLC. Clin Cancer Res 2022;28:4893-4906.
PMID: 35852792
|
|
|
|